# Pilot Study of Budesonide for Patients With Primary Sclerosing Cholangitis

> **NCT00004842** · PHASE1 · COMPLETED · sponsor: **National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)** · enrollment: 22 (actual)

## Conditions studied

- Cholangitis, Sclerosing
- Liver Cirrhosis, Biliary

## Interventions

- **DRUG:** budesonide

## Key facts

- **NCT ID:** NCT00004842
- **Lead sponsor:** National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1997-05
- **Primary completion:** 1999-04
- **Final completion:** 1999-04
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2017-05-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00004842

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00004842, "Pilot Study of Budesonide for Patients With Primary Sclerosing Cholangitis". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT00004842. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*